Abstract:AIM: To compare the differences between dideoxy sequencing/KRAS StripAssay/pyrosequencing for detection of KRAS mutation in Chinese colorectal cancer (CRC) patients.METHODS: Formalin-fixed, paraffin-embedded (FFPE) samples with tumor cells >= 50% were collected from 100 Chinese CRC patients at Beijing Cancer Hospital. After the extraction of genome DNA from FFPE samples, fragments contained codons 12 and 13 of KRAS exon 2 were amplified by polymerase chain reaction and analyzed by dideoxy sequencing, the KRAS StripAssay and pyrosequencing. In addition, the sensitivities of the 3 methods were compared on serial dilutions (contents of mutant DNA: 100%, 50%, 20%, 15%, 10%, 5%, 1%, 0%) of A549 cell line DNA (carrying the codon 12 Gly>Ser mutation) into wild-type DNA (human normal intestinal mucosa). The results of dideoxy sequencing, the KRAS StripAssay and pyrosequencing were analyzed by Chromas Software, Collector for KRAS StripAssay and the pyrosequencing PyroMarkTM Q24 system, respectively.RESULTS: Among 100 patients, KRAS mutations were identified in 34%, 37% and 37% of patients by dideoxy sequencing, the KRAS StripAssay and pyrosequencing, respectively. The sensitivity was highest with the KRAS StripAssay (1%), followed by pyrosequencing (5%), and dideoxy sequencing was lowest (15%). Six different mutation types were found in this study with 3 main mutations Gly12Asp (GGT>GAT), Gly12Val (GGT>GTT) and Gly13Asp (GGC>GAC). Thirty-three patients were identified to have KRAS mutations by the 3 methods, and a total of 8 patients had conflicting results between 3 methods: 4 mutations not detected by dideoxy sequencing and the KRAS StripAssay were identified by pyrosequencing; 3 mutations not detected by dideoxy sequencing and pyrosequencing were identified by the KRAS StripAssay; and 1 mutation not detected by pyrosequencing was confirmed by dideoxy sequencing and the KRAS StripAssay. Among these discordant results, the results identified by dideoxy sequencing were consistent either with the KRAS StripAssay or with pyrosequencing, which indicated that the accuracy of dideoxy sequencing was high.CONCLUSION: Taking a worldwide view of reports and our results, dideoxy sequencing remains the most popular method because of its low cost and high accuracy. (C) 2010 Baishideng. All rights reserved.

Detection of K-ras mutation in advanced colorectal carcinoma by Pyrosequencing

Rapid Detection of K-ras Gene Point Mutation in Pancreatic Adenocarcinoma by Pyrosequencing

Values of Mutations of K-ras Oncogene at Codon 12 in Detection of Pancreatic Cancer: 15-Year Experience

Detection of K-ras Mutation in Colorectal Cancer and Its Clinicopathological Significance

[K-Ras Gene Mutation in Colorectal Cancer and Its Clinicopathologic Significance].

Comparative Analysis of Dideoxy Sequencing, the KRAS StripAssay and Pyrosequencing for Detection of KRAS Mutation.

Detection Of Kras Gene Mutations In Endoscopic Ultrasound-Guided Fine-Needle Aspiration Biopsy For Improving Pancreatic Cancer Diagnosis

Mutation Detection of K-ras Gene in Paraffin-Embedded Colorectal Cancer Tissues by Using Chip-Based TGCE

KRAS Mutation Detection Method Based on LNA and Allele Specific Amplification

Differential High-Resolution Melting Analysis for the Detection of K-ras Codons 12 and 13 Mutations in Pancreatic Cancer.

[Application of Matrix Assisted Laser Desorption Ionization-Time of Flight-Mass Spectrometry in Detecting K-ras Gene Mutation of Colorectal Cancer].

Relationship Between K-ras Mutational Status and Clinical Pathological Characteristics in Colorectal Cancer

Analysis of KRAS mutations in circulating tumor DNA and colorectal cancer tissue

The relationship between K-ras gene mutation with clinicopathological and prognosis in gallbladder carcinoma

[High-throughput screening method of KRAS mutations at codons 12 and 13 in formalin-fixed paraffin-embedded tissue specimens of metastatic colorectal cancer]

Rapid detection of low-abundance K-ras mutation in stools of colorectal cancer patients using chip-based temperature gradient capillary electrophoresis

A novel approach to detect KRAS/BRAF mutation for colon cancer: Highly sensitive simultaneous detection of mutations and simple pre-treatment without DNA extraction

Detection of KRAS Mutation in Pancreatic Cancer and Colorectal Cancer Patients with Highly Sensitivite COLD-PCR

Detection of KRAS Gene Mutation and Its Clinical Significance in Colorectal Adenocarcinoma

Detection of KRAS mutations and their associations with clinicopathological features and survival in Chinese colorectal cancer patients.

Comprehensive Validation of Snapback Primer-Based Melting Curve Analysis to Detect Nucleotide Variation in the Codon 12 and 13 of KRAS Gene